×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
New Name, New Investment, New CEO for Fluidigm
Medical Device and Diagnostic industry
The company is set to change its name to Standard BioTools and will close on a $250 million investment.
5 months ago
Fluidigm (FLDM) Reports Q2 Loss, Tops Revenue Estimates
Yahoo Movies UK
Fluidigm (FLDM) delivered earnings and revenue surprises of -2.44% and 0.50%, respectively, for the quarter ended June 2018. Do the numbers hold clues to...
1 week ago
Will Fluidigm's Next Quarter Be a Bomb?
AOL.com
There's no foolproof way to know the future for Fluidigm (NAS: FLDM) or any other company. However, certain clues may help you see potential stumbles before...
1 week ago
Why Fluidigm's Stock Is Trading Higher Today
AOL.com
Fluidigm (NASDAQ: FLDM) shares are trading higher on Wednesday after the company announced it has received emergency use authorization from the FDA for the...
2 weeks ago
Standard BioTools and SomaLogic join forces in $1bn merger
Medical Device Network
Standard Biotools shareholders will own 43% of the combined company, and Somalogic shareholders will own 57%.
7 months ago
Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024
GlobeNewswire
SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB)...
3 weeks ago
Standard BioTools to Combine with SomaLogic in $1 Billion Merger
Bloomberg
Standard BioTools Inc. and SomaLogic Inc. have agreed to merge in an all-stock deal to combine suppliers of tools to the medical research...
7 months ago
Fluidigm scores $250M investment in microfluidics tech and a corporate makeover to boot
Fierce Biotech
First up: the investment, which will flood $250 million into Fluidigm, including an upfront payment of $25 million in convertible unsecured term...
27 months ago
Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results ...
Yahoo Finance
SOUTH SAN FRANCISCO, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing...
3 months ago
Fluidigm Provides More Details on Polaris System, New C1 Applications
GenomeWeb
At AGBT, Fluidigm showcased the Polaris system for integrated single-cell analysis and new applications for the C1,...
110 months ago